These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 22992788)
21. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS. Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739 [TBL] [Abstract][Full Text] [Related]
22. Identification of the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer patients using SELDI-TOF-MS and artificial neural networks. Yuan Y; Tan CW; Shen H; Yu JK; Fang XF; Jiang WZ; Zheng S Hepatogastroenterology; 2012; 59(120):2461-5. PubMed ID: 22497949 [TBL] [Abstract][Full Text] [Related]
23. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses]. Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756 [TBL] [Abstract][Full Text] [Related]
24. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639 [TBL] [Abstract][Full Text] [Related]
25. Detection and significance of serum protein markers of small-cell lung cancer. Han M; Liu Q; Yu J; Zheng S J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318 [TBL] [Abstract][Full Text] [Related]
26. Proteomic studies of early-stage and advanced ovarian cancer patients. Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221 [TBL] [Abstract][Full Text] [Related]
27. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma. Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882 [TBL] [Abstract][Full Text] [Related]
28. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]. Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154 [TBL] [Abstract][Full Text] [Related]
29. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
30. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
31. [Application of serum proteomic mass spectrum analysis in breast cancer]. Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387 [TBL] [Abstract][Full Text] [Related]
32. [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers]. Tian WD; Zeng ZY; Yu WB; Li XP Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1282-7. PubMed ID: 20584658 [TBL] [Abstract][Full Text] [Related]
33. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma]. Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807 [TBL] [Abstract][Full Text] [Related]
34. [Dynamic changes of serum proteomic spectra in patients with non-Hodgkin's lymphoma (NHL) before and after chemotherapy and screening of candidate biomarkers for NHL]. Ling JY; Sun XF; Zhang X; Zhen ZJ; Xia Y; Luo WB; Lin H; Zheng L Ai Zheng; 2008 Oct; 27(10):1065-9. PubMed ID: 18851786 [TBL] [Abstract][Full Text] [Related]
35. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer. Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881 [TBL] [Abstract][Full Text] [Related]
36. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma. Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569 [TBL] [Abstract][Full Text] [Related]
37. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer]. Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540 [TBL] [Abstract][Full Text] [Related]
38. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine]. Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811 [TBL] [Abstract][Full Text] [Related]
39. Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908 [TBL] [Abstract][Full Text] [Related]
40. [Application of serum protein pattern model in diagnosis of colorectal cancer]. Chen YD; Zheng S; Yu JK; Hu X Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):417-20. PubMed ID: 15355647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]